.png)
Agenzia Italiana del Farmaco
Webinar "Causality and chance in recent pharmacovigilance signals of Covid-19 vaccines: what evidence for public health decisions?" - Webinar "Causality and chance in recent pharmacovigilance signals of Covid-19 vaccines: what evidence for public health decisions?"
Webinar "Causality and chance in recent pharmacovigilance signals of Covid-19 vaccines: what evidence for public health decisions?"
The second scientific seminar “Causality and chance in recent pharmacovigilance signals of Covid-19 vaccines: what evidence for public health decisions?” organised by the Italian Medicines Agency took place on Thursday 15 April.
The moderator of the scientific seminar, held in English, was Nicola Magrini, Director General of the Italian Medicines Agency (AIFA), who discussed with Bernard Bégaud, Emeritus Professor of Clinical Pharmacology at the University of Bordeaux and Chair of the Scientific Committee EPI-PHARE.
Published on: 08 April 2021
Contacts
Via del Tritone, 181 00187 Roma
VAT number: 08703841000
Tax code: 97345810580
IPA AIFA code: aifa_rm
IPA UCB code: UFE1TR